en
Scientific article
English

Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS

Published inNeurology® neuroimmunology & neuroinflammation, vol. 2, no. 5, e144
Publication date2015
Abstract

To monitor the systemic immune responses of patients with multiple sclerosis (MS) under treatment with GNbAC1, a monoclonal antibody against the envelope protein of the MS- associated retrovirus, during a phase 2a trial.

Citation (ISO format)
ZIMMERMANN, Maria et al. Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS. In: Neurology® neuroimmunology & neuroinflammation, 2015, vol. 2, n° 5, p. e144. doi: 10.1212/NXI.0000000000000144
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2332-7812
394views
0downloads

Technical informations

Creation11/30/2016 2:42:00 PM
First validation11/30/2016 2:42:00 PM
Update time03/15/2023 1:06:00 AM
Status update03/15/2023 1:06:00 AM
Last indexation01/16/2024 10:36:35 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack